BONUSCAP-ZERTIFIKAT - PFIZER INC | Real-time BOERSE MUENCHEN 14:45:56 23/05/2024 BST | ||
| 28.56 EUR | -1.31% |
|
| Current month | +16.37% | ||
| 1 month | +13.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 28.56 | -1.31% |
| 22/05/24 | 28.94 | +2.73% |
| 21/05/24 | 28.17 | +0.28% |
| 20/05/24 | 28.09 | -0.28% |
| 17/05/24 | 28.17 | -1.19% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 02:45 pm
More quotesStatic data
| Product type | Certificats Bonus |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
UniCredit
|
| WKN | HC7MY6 |
| ISIN | DE000HC7MY62 |
| Date issued | 23/06/2023 |
| Strike | 42 $ |
| Maturity | 20/12/2024 (211 Days) |
| Parity | 1 : 1 |
| Emission price | 37.26 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 37.8 € |
|---|---|
| Lowest since issue | 24.5 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.6
USD
Average target price
31.94
USD
Spread / Average Target
+7.90%
- Stock Market
- Certificates
- Certificat
